UVT-15401-04055
1 vaccination
3 coded responses
3 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 123 / NY
- Registered
- 2021-05-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-05-28
Registered in v-safe
-
2021-06-23
Survey response — 3 months, dose 1MedDRA: Chest pain, Dyspnoea, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Chest pain and shortness of breath. · Healthcare visit (other): CardiologyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-23
Report sent to call center — 3 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-29
- 2021-07-02
-
2021-09-22
Survey response — 6 months, dose 1MedDRA: Dizziness, Headache — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Onset of chronic dizziness and headache.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-22
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-27
-
2022-03-24
Survey response — 12 months, dose 1MedDRA: Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Heart palpitationsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-24
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
-
2022-03-25
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-23 | Successful | Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2021-09-22 | Successful | Reported to VAERS voluntarily prior to GDIT contact |
| 2022-03-24 | Successful 2022-03-25 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 9 — 3 months, dose 1
Release 9 — 6 months, dose 1
Symptoms: Onset of chronic dizziness and headache.
Release 11 — 12 months, dose 1
Symptoms: Heart palpitations
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release